1-O-(1Z-hexadecenyl)-2-(14-hydroxy-4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Metabolite details

Identifier

QHFOWXSGAYXXMA-GBCDHVKLSA-N

InChI Key

QHFOWXSGAYXXMA-GBCDHVKLSA-N

IUPAC name

Preferred name

1-O-(1Z-hexadecenyl)-2-(14-hydroxy-4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

INN name

—

Synonym

PE(P-16:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)(14OH))

ChEBI

CHEBI:138546

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation

Observed in differential profiles

• Control_vs_OXPA_Treatment
• Control_vs_OXPA_Treatment
• Control_vs_Exercise